Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Plos One|October 13, 2017
Correction: Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysisDeyao Shi, Fashuai Wu, Feng Gao, et al.Plos One|June 9, 2017
Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysisDeyao Shi, Fashuai Wu, Feng Gao, et al.BMC Cancer|October 26, 2019
Prognostic significance of 8-hydroxy-2'-deoxyguanosine in solid tumors: a meta-analysisXiangcheng Qing, Deyao Shi, Xiao Lv, et al.Oncotargets and Therapy|September 4, 2018
Prognostic and clinicopathological significance of DEPTOR expression in cancer patients: a meta-analysisBinwu Hu, Deyao Shi, Xiao Lv, et al.Journal of Cancer|July 21, 2018
Prognostic Value of Programmed Cell Death 1 Ligand-1 (PD-L1) or PD-1 Expression in Patients with Osteosarcoma: A Meta-AnalysisXin Huang, Weiyue Zhang, Zhicai Zhang, et al.Oncotargets and Therapy|August 3, 2019
Lycorine exerts antitumor activity against osteosarcoma cells in vitro and in vivo xenograft model through the JAK2/STAT3 pathwayHongzhi Hu, Shangyu Wang, Deyao Shi, et al.BMC Cancer|July 15, 2018
Prognostic and clinicopathological significance of MLKL expression in cancer patients: a meta-analysisBinwu Hu, Deyao Shi, Xiao Lv, et al.Journal of Cellular and Molecular Medicine|February 7, 2021
Prognostic role of c-Jun activation domain-binding protein-1 in cancer: A systematic review and meta-analysisDeyao Shi, Shidai Mu, Binwu Hu, et al.Frontiers in Immunology|November 8, 2021
International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell LymphomaShidai Mu, Deyao Shi, Lisha Ai, et al.Anti-Cancer Drugs|February 9, 2018
Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen speciesXiangcheng Qing, Zengwu Shao, Xiao Lv, et al.Pageof 5